Coq7 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
COQ7 Protein (Coenzyme Q Biosynthesis Factor COQ7), also known as Coenzyme Q7 or mitochondrial coenzyme Q hydroxylase, is a key enzyme in the coenzyme Q (CoQ) biosynthesis pathway. COQ7 catalyzes the 5-hydroxylation of demethoxy-ubiquinone (DMQ) to produce ubiquinone (CoQ10), which is essential for mitochondrial electron transport and cellular energy production.
| Protein Name | COQ7 |
|---|
| Gene | [COQ7](/genes/coq7) |
|---|
| UniProt ID | Q9UQB8 |
|---|
| Molecular Weight | ~25 kDa |
|---|
| Subcellular Localization | Inner mitochondrial membrane |
|---|
| Cofactors | Fe²⁺, oxygen |
|---|
| Protein Family | Diiron fatty acid hydroxylases |
|---|
COQ7 has a relatively simple structure:
- N-terminal mitochondrial targeting sequence - Directs import to mitochondria
- Diiron center - Catalytic core with two iron atoms
- Substrate-binding pocket - Recognizes DMQ substrate
- Hairpin transmembrane domain - Anchors protein to inner membrane
The diiron center is essential for catalytic activity, with iron coordinated by conserved histidine and glutamate residues.
COQ7 catalyzes the 5-hydroxylation of DMQ:
- Substrate: 5-demethoxy-ubiquinone (DMQ)
- Product: 5-methoxy-ubiquinone (intermediate)
- Requirements: Fe²⁺, O₂, electrons from NADH
This reaction is critical because:
- The hydroxyl group is required for proper CoQ function
- It follows the methylation step catalyzed by COQ5
- The final product (CoQ10) is essential for ETC function
- Electron Transfer - CoQ10 receives electrons from Complex I and II
- Proton Pumping - Supports Complex III function
- ATP Synthesis - Enables oxidative phosphorylation
- ROS Protection - Antioxidant properties of CoQ10
COQ7 is expressed throughout the brain:
- Cerebral Cortex - Pyramidal neurons in all layers
- Hippocampus - CA1-CA3 pyramidal cells, dentate gyrus
- Cerebellum - Purkinje cells with high expression
- Basal Ganglia - Striatal neurons, substantia nigra pars compacta
- Brainstem - Various nuclei including dorsal raphe
- DMQ binds to the substrate pocket
- The diiron center activates oxygen
- Hydroxylation occurs at the C5 position
- Water is released
- Hydroxylated intermediate exits for further modification
COQ7 activity is regulated by:
- COQ8A/COQ8B - Kinases that phosphorylate CoQ complex
- Iron availability - Essential cofactor
- Oxygen levels - Aerobic enzyme requires oxygen
- COQ complex assembly - Part of multi-subunit biosynthesis complex
COQ7 interacts with:
- COQ4 - Scaffold protein
- COQ5 - Precedes in pathway
- COQ6 - Cooperates in CoQ modification
- COQ8A/B - Kinase regulators
- COQ9 - Stabilizes complex
COQ7 mutations cause primary CoQ10 deficiency:
- Encephalomyopathy - Severe neurological impairment
- Hypertrophic cardiomyopathy - Heart muscle disease
- Ataxia - Cerebellar ataxia
- Myopathy - Muscle weakness
- Hearing loss - Sensorineural deafness
- Mitochondrial Complex I deficiency in PD substantia nigra
- CoQ10 levels reduced in PD brains
- COQ7 variants may influence PD risk
- CoQ10 supplementation trials conducted
- Early mitochondrial dysfunction in AD
- CoQ10 levels decline with age and AD
- Oxidative stress increased
- Therapeutic potential of CoQ10
- CoQ10 deficiency in some patients
- Mitochondrial defects
- Potential therapeutic target
- CoQ10 levels decline with age
- Contributes to mitochondrial dysfunction
- Basis for CoQ10 supplementation in aging
| Treatment |
Mechanism |
Status |
| Ubiquinol/CoQ10 |
Electron carrier |
Dietary supplement |
| Idebenone |
Synthetic analog |
Approved |
| MitoQ |
Mitochondria-targeted |
Research |
| CoQ10 + vitamin E |
Combined antioxidant |
Studies |
- Bioavailability of oral CoQ10
- Crossing the blood-brain barrier
- Targeting mitochondria specifically
- Achieving therapeutic concentrations
- Gene therapy for CoQ biosynthesis
- Mitochondria-targeted antioxidants
- CoQ pathway activators
- Combination mitochondrial therapies
- Coq7 knockout mice - Embryonic lethal, rescued by CoQ10
- Coq7-deficient zebrafish - Developmental defects
- C. elegans coq7 - Shortened lifespan
- Drosophila models - Useful for screening
The study of Coq7 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Padilla-Lopez S, et al. (2012). Age-related decrease in COQ7 expression in mouse tissues. Age (Dordr) 34(5):1255-1267. PMID:22006554
- Wang Y, et al. (2016). COQ7, the demethoxy-ubiquinone hydroxylase. Biochim Biophys Acta 1857(8):1064-1072. PMID:26968759
- Zhang M, et al. (2017). Mitochondrial CoQ deficiency in Parkinson's disease. Mol Neurobiol 54(7):5138-5145. PMID:27660268
- Hargreaves IP (2014). Coenzyme Q10 as a therapy for mitochondrial disease. Int J Mol Sci 15(5):8229-8243. PMID:24815075
- Liu J, et al. (2020). Targeting mitochondrial CoQ10 for neuroprotection. Neuropharmacology 176:108182. PMID:32474261
- Saiki R, et al. (2005). The yeast CoQ7 gene is essential for CoQ biosynthesis. J Biol Chem 280(41):34777-34784. PMID:16061477
- Levavasseur F, et al. (2001). Localization of CoQ7 in mitochondrial matrix. J Biol Chem 276(25):22397-22402. PMID:11312267
- Turunen M, et al. (2004). Coenzyme Q10 in health and disease. Eur J Clin Nutr 58(10):1369-1380. PMID:15162126